CTOs on the Move


 
Rgenix is a preclinical stage pharmaceutical company with a mission to develop the world`s first cancer therapies designed specifically to target cancer metastasis, the main cause of mortality in cancer patients. Rgenix is leading the revolution in next-generation cancer therapies with first-in-class lead drug candidates for several aggressive cancer subtypes, including Triple-Negative Breast Cancer, Melanoma and Colorectal Cancer.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.rgenix.com
  • 310 East 67th Street Suite 1-12
    ‎New York, NY USA 10065
  • Phone: 646.856.9261

Executives

Name Title Contact Details

Funding

Rgenix raised $33M on 06/15/2016

Similar Companies

Apeel Sciences

Apeel Sciences creates products from natural plant extracts that allow growers to reduce reliance on pesticides, increase produce quality, and provide superior shelf life without refrigeration.

Vital Probes Inc

Vital Probes Inc is a Jermyn, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Surrozen

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.

Pharm Agra Labs

Pharm Agra Labs is a Brevard, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Memphis Bio Works

Memphis Bio Works is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.